E79 Gold Mines Limited (ASX: E79) has delivered a promising exploration update from its Laverton South Gold Project (Figure 1), with significant gold intercepts reported from reconnaissance aircore drilling at the emerging T14 South gold prospect. These results reinforce the potential of this structurally complex target and open the door for near-term discovery catalysts as further assays are pending.

Proteomics International Laboratories (ASX: PIQ) has unveiled new results for its PromarkerEso blood test, a patented, first-in-class diagnostic that delivers a simple and scalable pathway for early detection. With clinical validation showing high accuracy in identifying early-stage EAC, PromarkerEso may well change the standard of care in managing this difficult disease. With patents already granted in Europe, China, and Australia—and other territories pending.

Actinogen Medical Limited (ASX: ACW) has announced a significant milestone in the development of Xanamem®, its lead therapy for Alzheimer’s disease (AD). Following a successful Type C meeting with the US Food and Drug Administration (FDA), the Company now has clear guidance on the remaining clinical, manufacturing, and regulatory requirements for a New Drug Application (NDA) submission in the US.

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE), a biotechnology company focused on disease-modifying treatments for neurodegenerative diseases, has successfully raised A$20.0 million through a strategic placement to international and Australian professional investors.

Temas Resources Corp, incorporated in British Columbia, Canada, is bringing a unique blend of critical mineral projects and proprietary metallurgical technology to the Australian Securities Exchange. The company already trades on the CSE, OTCQB, and FSE, and is now seeking to broaden its investor base through an ASX listing.

DY6 Metals (ASX:DY6) has taken another significant step toward establishing itself as the dominant rutile player in Central Africa. By securing the historically significant Yaoundé West Project, the Company has added a proven production site to its growing Central Rutile Project (Figure 1). This acquisition is more than just additional ground.

OD6 Metals Limited (ASX: OD6) has released results from its CPC Engineering Optioneering Study, confirming that heap leaching is the lower-cost and preferred primary leach option for the Splinter Rock Rare Earth Project (Figure 1). This is a significant step in de-risking the project and optimising development economics, with the study showing heap leach delivers superior recovery, lower capital intensity, and simplified operations when compared to conventional agitated tank

EQ Resources Ltd (ASX: EQR) has released an update on operations at its 100%-owned Saloro tungsten mine in Spain, underscoring its strategy to lift efficiency and build on the improving tungsten price environment. The commissioning of a third XRT Ore Sorter marks a step-change in throughput capacity and cost optimisation, while the company has also commenced a periodic Ore Reserve update expected in Q4 CY2025.

The Revolution Private Credit Income Trust (ASX: REV) is set to provide investors with institutional-quality access to the Australian and New Zealand private credit market. This listed investment trust will focus on high-quality secured loans, asset-backed securities, and commercial real estate loans, aiming to generate reliable monthly income underpinned by disciplined underwriting standards.

Ariana Resources Plc (ASX: AA2 | AIM: AAU) is entering into the ASX spotlight with a dual listing that combines global operational success with a bold growth vision anchored in Zimbabwe’s emerging gold sector. With producing mines in Türkiye and a 100%-owned flagship gold project at Dokwe in Zimbabwe (Figure 1), Ariana offers a rare blend of cash-generating assets, a robust pipeline, and resource expansion upside.